Literature DB >> 8248546

De novo synthesis of phospholipase A2 and prostacyclin production by proliferating rat smooth muscle cells.

Y Uehara1, S Takada, N Hirawa, Y Kawabata, T Nagata, A Numabe, H Hara, I Kudo, T Ikeda, K Inoue.   

Abstract

We investigated the role of phospholipase A2 (PLA2) in cell cycle-dependent alterations of endogenous prostacyclin (PGI2) synthesis in aortic smooth muscle cells in culture (VSMC) from Wistar Kyoto rats. Randomly cycling VSMC generated more PGI2 than the stationary cells. Cell cycle analysis showed that PGI2 production capacity was increased from the G0/G1 through the early DNA synthetic (S) phases. Enzyme analysis revealed that, although there were different mechanisms underlying this increase in the PGI2 production during the G0/G1, the peak at 4 hours coincided with a sharp increase in PLA2 activity. This increase in PLA2 activity was preceded by an increased expression of functional PLA2 messenger RNA, and protein synthesis inhibition prevented most of the increase in PGI2 production at 4 hours. These data indicate that endogenous PGI2 generation is mainly increased during the G0/G1 period and that this event is secondary to de novo synthesis of PLA2 and probably, at least in part, to cyclooxygenase induction. This mechanism provides a negative feedback regulating VSMC proliferation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248546     DOI: 10.1016/0090-6980(93)90098-r

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  2 in total

1.  Role of COX-2 in the bioactivation of methylenedianiline and in its proliferative effects in vascular smooth muscle cells.

Authors:  Valeria Y Hebert; Brandon Chad Jones; Randy C Mifflin; Tammy R Dugas
Journal:  Cardiovasc Toxicol       Date:  2011-12       Impact factor: 3.231

2.  Newly manufactured Marukome MK-34-1 miso with angiotensin-converting enzyme inhibitory activity and its antihypertensive effects in genetic hypertensive rat models.

Authors:  Hiroe Sakuyama Tomari; Misa Uchikawa; Aki Yamazaki; Satomi Hirabayashi; Shoko Yamakawa; Manabu Kitagawa; Minami Yamada; Seiki Itou; Tetsuro Yamamoto; Yoshio Uehara
Journal:  Hypertens Res       Date:  2019-01-10       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.